CorMedix (CRMD) Cash & Equivalents (QoQ) (2010 - 2025)
CorMedix (CRMD) Cash & Equivalents (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | CorMedix | 4.95 Mn | -150.26 Mn | 107.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 198.68% |
| Sep 30, 2025 | -69.56% |
| Jun 30, 2025 | 140.34% |
| Mar 31, 2025 | 63.06% |
| Dec 31, 2024 | 15.20% |
| Sep 30, 2024 | 23.63% |
| Jun 30, 2024 | -18.87% |
| Mar 31, 2024 | -19.39% |
| Dec 31, 2023 | -18.14% |
| Sep 30, 2023 | 170.63% |
| Jun 30, 2023 | -22.04% |
| Mar 31, 2023 | -41.44% |
| Dec 31, 2022 | -0.24% |
| Sep 30, 2022 | 91.03% |
| Jun 30, 2022 | 0.31% |
| Mar 31, 2022 | -57.66% |
| Dec 31, 2021 | 135.60% |
| Sep 30, 2021 | -69.04% |
| Jun 30, 2021 | -4.10% |
| Mar 31, 2021 | 899.31% |